
Stivarga 40 mg Tablet contains Regorafenib, an oral targeted therapy used to treat certain types of cancers such as metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (liver cancer).
| Generic Name | Regorafenib |
| Manufacturer | Bayer |
| Packing | 28 Tablets in 1 Bottle |
| Prescribed For | Metastatic Colorectal Cancer, GIST, and Hepatocellular Carcinoma |
| Availability | In Stock |




As a fully licensed supplier of high-quality generic anticancer medicines, we provide Stivarga 40 mg Regorafenib tablets, commonly used for the treatment of metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (liver cancer).
We ensure safe, consistent, and timely bulk supply of oncology drugs, including Generic Stivarga, to hospitals, clinics, pharmacies, healthcare providers, physicians, NGOs, and authorized buyers in over 80 countries worldwide. Our distribution network spans Latin America, Africa, Asia, Europe, the Middle East, and North America, covering regions such as Mexico, Brazil, Colombia, Peru, Chile, UAE, Saudi Arabia, Egypt, South Africa, Namibia, Kenya, Nigeria, Singapore, Vietnam, Thailand, the Philippines, Canada, and many more.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.